Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-26

FDA Approved: ATAZANAVIR SULFATE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for atazanavir sulfate (atazanavir) under an ANDA from Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • atazanavir sulfate (atazanavir)

Snippet

SUPPL AP for ATAZANAVIR SULFATE (ATAZANAVIR)